about 2 months ago // Global Health
Analysts expect an 80% drop in prices once semaglutide goes generic. But experts warn that booming demand in wealthy countries may leave diabetes patients in low- and middle-income countries behind.
3 months ago // Technology
Countries such as India and Brazil have pioneered a new approach to digital public infrastructure. With foreign aid shrinking, could it offer a more collaborative, cost-effective approach to development — and what are the risks?
4 months ago // Data and development
For years, data has been collected about the global south by governments, INGOs, and U.N. agencies. Communities haven't had power over what was collected, nor have they seen results of the research. Now, it's time for a change.
4 months ago // UNGA 2025
Experts on air pollution raise alarms over the problem's absence from the upcoming declaration on noncommunicable diseases at the U.N. General Assembly.
5 months ago // Democracy and governance
A year after its prime minister was ousted by a popular uprising, NGOs are disappointed in the country's lack of progress toward allowing them to do their work.
7 months ago // WASH
Strains on the Indus Water Treaty highlight the increasing pressure on shared resource agreements from climate change and rising geopolitical competition.
7 months ago // Global Health
WHO’s new strategy on traditional medicine seeks to bridge ancient healing practices with modern scientific standards — but not without controversy.
8 months ago // Global health
Some 14.5 million children have never received a single vaccine. Most live in conflict zones, far from government reach. Gavi’s ZIP model is rewriting the rules — partnering with neutral players to deliver vaccines where health systems can’t.
10 months ago // Global health
The U.S. has scaled back foreign aid, and the consequences could be dire. Without funding for antimicrobial resistance programs, the world faces a growing crisis — one where infections once easily treated become untreatable, experts warn.
10 months ago // Global health
New breakthrough drugs and research could help to end major global epidemics such as malaria and HIV. But U.S. funding cuts threaten to derail progress.